FTC Takes Deeper Look At $919M Biotech Merger
The U.S. Federal Trade Commission has put the brakes on biotechnology giant Genentech Inc.'s proposed $919 million acquisition of Tanox Inc., demanding more information on the potential union before the deal...To view the full article, register now.
Already a subscriber? Click here to view full article